Pablito is also dismissing the observation and recommendation by the IDMC to conclude the Hervaxx trial as soon as possible as it is not ethical to continue to herd the poor patients onto the chemo only arm knowing that it is far, far inferior to the arm with Hervaxx. Maybe Pablito should have dismissed the IDMC panel and become the panel himself. You know, like Scotty making himself a cabinet of one and makes all decision based on a P value of 0.05
IMU Price at posting:
19.3¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)